Labcorp Holdings Inc Revenue Growth Rates (LH), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Labcorp Holdings Inc   (NYSE: LH)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

LH's Revenue Growth by Quarter and Year

Labcorp Holdings Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/LH/growth
https://api.csimarket.com/api/v1/companies/LH/fundamentals
https://api.csimarket.com/api/v1/companies/LH/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
LH Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 3,810.00
2nd Quarter June 3,731.10
1st Quarter March 3,537.60
FY 11,078.70

LHs Annual Revenue
Labcorp Holdings Inc 's Revenue in the fiscal year 2025 $ 13,951.70 millions
Labcorp Holdings Inc 's Revenue in the fiscal year 2024 $ 13,008.90 millions
Labcorp Holdings Inc 's Revenue in the fiscal year 2023 $ 12,161.60 millions
Labcorp Holdings Inc 's Revenue in the fiscal year 2021 $ 14,876.80 millions
Labcorp Holdings Inc 's Revenue in the fiscal year 2020 $ 13,978.50 millions




LH Revenue third quarter 2026 Y/Y Growth Comment
Labcorp Holdings Inc reported Revenue growth of 6.92% year on year in the third quarter 2026, to $ 3,810.00 millions, this is lower than Labcorp Holdings Inc 's recent average Revenue increase of 12.01%.

Looking into third quarter 2026 results within Medical Laboratories industry 19 other companies have achieved higher Revenue growth. While Labcorp Holdings Inc ' s Revenue increase of 6.92% ranks overall at the positon no. 2110 in the third quarter 2026.


LH Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 6.92 %
2nd Quarter June 5.78 %
1st Quarter March 5.75 %
FY   -

Financial Statements
Labcorp Holdings Inc 's third quarter 2026 Revenue $ 3,810.00 millions LH's Income Statement
Labcorp Holdings Inc 's third quarter 2025 Revenue $ 3,563.50 millions Quarterly LH's Income Statement


LH Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 2.11 %
2nd Quarter June 5.47 %
1st Quarter March 0.62 %
FY (Year on Year)   -


Back to LH Growth rate Comparisons >> Back to LH Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #20
Healthcare Sector #313
Overall #2110

Revenue Y/Y Growth Statistics
High Average Low
444.03 % 12.01 % -74.97 %
 
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #20
Healthcare Sector #313
Overall #2110
Revenue Y/Y Growth Statistics
High Average Low
444.03 % 12.01 % -74.97 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Labcorp Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
329.52 % 4.82 % -75.3 %
(Mar 31 2016)  


LH's III. Quarter Q/Q Revenue Comment
Labcorp Holdings Inc achieved in the III. Quarter 2026 below company average Revenue growth of 2.11% quarter on quarter, to $ 3,810.00 millions.

Although the III. Quarter 2026 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the III. Quarter surge, eclipses the 1.03% growth in the III. Quarter a year ago

Within Medical Laboratories industry 12 other companies have achieved higher Revenue quarter on quarter growth. While Labcorp Holdings Inc 's Revenue growth quarter on quarter, overall rank is 1497.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #13
Healthcare Sector #203
Overall #1497
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #13
Healthcare Sector #203
Overall #1497
Revenue Q/Q Growth Statistics
High Average Low
329.52 % 4.82 % -75.3 %
(Mar 31 2016)  


LH's III. Quarter Q/Q Revenue Comment
Labcorp Holdings Inc achieved in the III. Quarter 2026 below company average Revenue growth of 2.11% quarter on quarter, to $ 3,810.00 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 1.03% in the III. Quarter a year ago.

Within Medical Laboratories industry 12 other companies have achieved higher Revenue quarter on quarter growth. While Labcorp Holdings Inc 's Revenue growth quarter on quarter, overall rank is 1497.


Labcorp Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 14,594.50
Y / Y Revenue Growth (TTM) 6.02 %
Year on Year Revenue Growth Overall Ranking # 1823
Seqeuential Revenue Change (TTM) 1.72 %
Seq. Revenue Growth (TTM) Overall Ranking # 1823


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Labcorp Holdings Inc 's cumulative twelve months Revenue were $ 14,595 millions, company would post below average annual Revenue growth of 1.72% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Labcorp Holdings Inc 's Revenue growth from the 13483.8% growth in Jun 30 2026.

In the Healthcare sector 269 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1823, from total ranking in previous quarter at 2062.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 18
Healthcare Sector # 270
Overall # 1712

Revenue TTM Y/Y Growth Statistics
High Average Low
157.75 %
 10.48 %
-41.65 %
(Mar 31 2016)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 346
S&P 500 # 2429
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Labcorp Holdings Inc 's cumulative twelve months Revenue were $ 14,595 millions, company would post below average annual Revenue growth of -41.65% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Labcorp Holdings Inc 's Revenue growth from the 13483.8% growth in Jun 30 2026.

In the Healthcare sector 269 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1823, from total ranking in previous quarter at 2062.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 18
Healthcare Sector # 270
Overall # 1712

Revenue TTM Y/Y Growth Statistics
High Average Low
157.75 %
10.48 %
-41.65 %
(Mar 31 2016)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 346
S&P 500 # 2429




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LH's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Vertex Pharmaceuticals Inc11.85%$ 11.845 millions
Sanara Medtech Inc 11.67%$ 11.668 millions
Lemaitre Vascular Inc 11.51%$ 11.508 millions
Pacs Group Inc 11.45%$ 11.454 millions
Ocugen Inc 11.36%$ 11.358 millions
Dexcom Inc 11.26%$ 11.263 millions
Elanco Animal Health Incorporated11.26%$ 11.258 millions
Koru Medical Systems Inc 11.19%$ 11.194 millions
Elite Pharmaceuticals Inc 11.11%$ 11.113 millions
Pro dex Inc 10.96%$ 10.955 millions
Nrc Health10.95%$ 10.954 millions
Anika Therapeutics Inc 10.91%$ 10.912 millions
Harvard Bioscience Inc 10.86%$ 10.864 millions
Repligen Corp10.86%$ 10.863 millions
Warby Parker Inc 10.77%$ 10.767 millions
Cerus Corporation10.69%$ 10.690 millions
Biogen Inc 10.63%$ 10.628 millions
Chemed Corporation10.57%$ 10.568 millions
Edwards Lifesciences Corporation10.47%$ 10.471 millions
Biodesix Inc 10.44%$ 10.442 millions
Medline Inc 10.41%$ 10.415 millions
Jazz Pharmaceuticals Plc10.38%$ 10.380 millions
Abbvie Inc 10.32%$ 10.319 millions
Livanova Plc10.17%$ 10.170 millions
Kura Oncology Inc 10.07%$ 10.067 millions
Amneal Pharmaceuticals Inc 10.04%$ 10.040 millions
Quest Diagnostics Inc9.98%$ 9.979 millions
Idexx Laboratories Inc9.95%$ 9.950 millions
Bausch Health Companies Inc 9.70%$ 9.698 millions
Marpai Inc9.59%$ 9.586 millions


About Labcorp Holdings Inc Revenue Growth Rates (LH), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Labcorp Holdings Inc (CIK 920148).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000920148-26-000222
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Labcorp Holdings Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.